Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Dow
UBS
Express Scripts
Chinese Patent Office
Federal Trade Commission
Baxter
Fuji
Johnson and Johnson

Generated: December 15, 2018

DrugPatentWatch Database Preview

Drug Price Trends for NITROFURANTOIN

« Back to Dashboard

Drug Price Trends for NITROFURANTOIN

Average Pharmacy Cost for NITROFURANTOIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NITROFURANTOIN MCR 50 MG CAP 68382-0559-01 0.51355 EA 2018-12-12
NITROFURANTOIN MONO-MCR 100 MG 68084-0446-11 0.67220 EA 2018-11-21
NITROFURANTOIN MCR 100 MG CAP 00378-1700-01 0.77733 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for NITROFURANTOIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NITROFURANTOIN 100MG CAP UD Mylan Institutional, Inc. 51079-0348-20 100 307.56 3.07560 EA 2017-11-15 - 2022-09-29 FSS
NITROFURANTOIN 100MG CAP UD Mylan Institutional, Inc. 51079-0348-20 100 283.42 2.83420 EA 2017-12-28 - 2022-09-29 FSS
NITROFURANTOIN MACROCRYSTALS 50MG CAP Mylan Institutional, Inc. 51079-0584-20 100UD 183.70 1.83700 EA 2017-11-15 - 2022-09-29 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
McKinsey
Baxter
Cipla
Teva
Daiichi Sankyo
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.